Mydecine Innovations Group Inc. (MYCOD)
OTCMKTS · Delayed Price · Currency is USD
0.2362
+0.0362 (18.10%)
At close: Oct 24, 2025
MYCOD Market Cap
MYCOD has a market cap or net worth of $291.73 thousand as of November 6, 2025. Its market cap has decreased by -22.56% in one year.
Market Cap
291.73K
Enterprise Value
5.45M
Revenue
n/a
Ranking
n/a
PE Ratio
1.80
Stock Price
$0.24
Market Cap Chart
Since May 8, 2015, MYCOD's market cap has decreased from 8.91M to 291.73K, a decrease of -96.72%. That is a compound annual growth rate of -27.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 291.73K | 68.71% |
| Dec 31, 2024 | 172.92K | -77.92% |
| Dec 29, 2023 | 783.26K | -85.99% |
| Dec 30, 2022 | 5.59M | -80.55% |
| Dec 31, 2021 | 28.75M | -53.51% |
| Dec 31, 2020 | 61.86M | 1,508.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 373.25M |
| American Oncology Network | 325.20M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 294.74M |